|
Frederick William Kredel Brown
|
| Title: |
Managing Director |
| Industry: |
Consulting |
| Type of Organization: |
Consulting and Research Firm |
| Major Product/Service: |
Custom market intelligence, strategic consulting and financial advisory services |
| Expertise: |
Mr. Brown is a global leader in healthcare business management and consulting. His influence in the U.S., Europe and emerging markets transforms business plans to profits. He has a proven ability to lead and coach executive teams, create and implement multifunctional strategy programs and launch and manage new businesses. Mr. Brown’s capabilities are valued worldwide across provider, payor, pharmaceutical and medical product markets. He serves on the Board of Directors of several healthcare companies. As a consultant and researcher, he is passionate about developing and implementing winning competitive and operational strategies for his clients across the healthcare value chain. |
| Geographic Area of Distribution: |
International |
| Affiliations: |
American Association for the Advancement of Science; American Chemical Society; Drug Information Association; The Kidney Foundation |
| University/Degree: |
B.S., Biology and Geology, Tufts University; M.B.A., Harvard Business School; Six Sigma; Certified Project Management |
| Born: |
March 24, 1959, Waterville, Maine |
| Hobbies/Sports: |
Physical fitness, alpine climbing, bridge, antique restoration |
| Spouse: |
Elizabeth |
| Children: |
Alex, Laura, Karl |
| Work History: |
Mr. Brown has a distinguished 30-year career in the healthcare industry working in various operating and consulting positions across supplier, provider and payer organizations. Brown most recently led the healthcare services division of the largest privately-owned specialty pharmacy in the U.S., serving as President of Navigator Health Services for Diplomat Specialty Pharmacy. He previously held a variety of positions, including serving as: The Global Head of Product Lifecycle Management and Partnering IM at Hoffman LaRoche; Executive Vice President of Global Service EMEA for IBM’s Life Sciences Division; Vice President of Life Sciences Europe and Worldwide Head of Chemicals at CSC; A Partner and co-founder of Andersen Consulting’s (Accenture) Pharmaceutical and Medical Products Practice in the U.S. and Europe selling and delivering major projects at 17 of the top 20 life science companies in the world. Mr. Brown also founded and led the world’s largest in depo injection company Alkermes (NASDAQ:ALK) early in his career. |
| Honors & Awards: |
Inc. 500 President of The Fastest Growing Healthcare Company, 2009; National Science Foundation Grant, Principal Investigator; Benjamin B. Brown Scholar; World Bank IDB Program Excellence; Who’s Who International, 2002 -2004 |
| Published Works: |
Regular speaker at international healthcare conferences; Regularly quoted in the media; Articles, peer-reviewed journals of record including "The Impact of the Affordable Care Act on the Medical Technology Industry", Journal of Medical Devices and Diagnostics |
| Career Accomplishments: |
More than 50 healthcare products have been successfully developed and launched around the world, thanks in part to Mr. Brown’s guidance in developing, launching and managing dozens of healthcare product and service lines. Today, his leadership generates $15 billion in annual revenue for healthcare product and service portfolios and his work saves an estimated 5.5 million lives annually around the globe. |
